Print Page   |   Contact Us   |   Your Cart   |   Sign In
Search
Sign In


Forgot your password?

Haven't registered yet?

Breaking News
Calendar
News & Press: Daily Updates

MMWR: Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of

Thursday, October 22, 2015   (0 Comments)

At its June 2015 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended that adolescents and young adults aged 16–23 years may be vaccinated with a serogroup B meningococcal (MenB) vaccine to provide short-term protection against most strains of serogroup B meningococcal disease. This report summarizes the deliberations of ACIP, the rationale for its decision, and recommendations for use of MenB vaccines in adolescents and young adults.

MORE >>


OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2016. Sponsorship does not imply endorsement by OSAP of a company's products or services.